Production (Stage)
Journey Medical Corporation
DERM
$7.12
-$0.27-3.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.30M | -14.67M | -18.34M | 843.00K | -4.16M |
| Total Depreciation and Amortization | 3.67M | 3.42M | 3.26M | 3.26M | 3.51M |
| Total Amortization of Deferred Charges | 346.00K | 307.00K | 215.00K | 186.00K | 401.00K |
| Total Other Non-Cash Items | 5.69M | 5.58M | 4.98M | 4.45M | 7.17M |
| Change in Net Operating Assets | -8.34M | -3.77M | -17.99M | -16.70M | -5.74M |
| Cash from Operations | -6.94M | -9.13M | -27.87M | -7.97M | 1.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -15.00M | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -15.00M | -15.00M | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 10.00M | 10.00M | 19.95M | 20.00M | 15.00M |
| Total Debt Repaid | -1.88M | -1.25M | -625.00K | -11.00M | -24.00M |
| Issuance of Common Stock | 10.88M | 8.29M | 6.64M | 6.28M | 6.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -50.00K | -380.00K | -380.00K | -471.00K |
| Cash from Financing | 18.95M | 16.99M | 25.58M | 14.90M | -3.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.99M | -7.13M | -2.29M | 6.93M | -2.04M |